Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Big Leap Health is a private digital health and mental healthcare infrastructure company focused on improving access to interventional psychiatry treatments. The company operates a patient-facing discovery and navigation platform for in-network clinics offering treatments such as Spravato (esketamine), transcranial magnetic stimulation, ketamine therapy, and related behavioral health services. It also provides a provider-facing business-in-a-box and MSO model that supports clinic launch, payer contracting, onboarding, credentialing, billing, prior authorization, and operational workflows. Rather than developing proprietary drugs, Big Leap Health appears to commercialize care-enablement and clinic-network infrastructure for breakthrough mental health treatment delivery. The business is aimed at making insurance-covered access to advanced mental health services easier for both patients and providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Big Leap.